Free Trial

vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume

vTv Therapeutics logo
$21.31 +1.36 (+6.82%)
Closing price 05/1/2025 03:58 PM Eastern
Extended Trading
$21.31 0.00 (0.00%)
As of 04:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

vTv Therapeutics Short Interest Data

vTv Therapeutics (VTVT) has a short interest of 22,900 shares, representing 1.55% of the float (the number of shares available for trading by the public). This marks a 42.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 23,268 shares to cover all short positions.

Current Short Interest
22,900 shares
Previous Short Interest
16,100 shares
Change Vs. Previous Month
+42.24%
Dollar Volume Sold Short
$425,482.00
Short Interest Ratio
1.0 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
3,190,000 shares
Float Size
1,480,000 shares
Short Percent of Float
1.55%
Today's Trading Volume
4,798 shares
Average Trading Volume
23,268 shares
Today's Volume Vs. Average
21%
Short Selling vTv Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VTVT Short Interest Over Time

VTVT Days to Cover Over Time

VTVT Percentage of Float Shorted Over Time

vTv Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202522,900 shares $425,482.00 +42.2%1.6%1 $18.58
3/31/202516,100 shares $278,852.00 -34.3%1.1%0.7 $17.32
3/15/202524,500 shares $363,825.00 +1.7%1.7%1.1 $14.85
2/28/202524,100 shares $473,806.00 -13.6%1.6%1.8 $19.66
2/15/202527,900 shares $605,430.00 +4.5%1.9%1.8 $21.70
1/31/202526,700 shares $417,054.00 +18.7%1.8%1.1 $15.62
1/15/202522,500 shares $316,125.00 +33.1%1.5%0.8 $14.05
12/31/202416,900 shares $233,389.00 No Change1.1%0.6 $13.81
12/15/202416,900 shares $254,007.00 -24.9%1.1%0.6 $15.03
11/30/202422,500 shares $360,900.00 -17.3%1.6%0.7 $16.04
11/15/202427,200 shares $469,200.00 -5.9%1.9%0.9 $17.25
10/31/202428,900 shares $396,508.00 -0.3%2.2%1 $13.72
10/15/202429,000 shares $386,860.00 -7.9%2.3%1 $13.34
9/30/202431,500 shares $424,620.00 +1.6%2.4%1.1 $13.48
9/15/202431,000 shares $442,060.00 -6.3%2.4%1 $14.26
8/31/202433,100 shares $520,001.00 -13.1%2.6%1.2 $15.71
8/15/202438,100 shares $513,969.00 +34.6%3.0%1.5 $13.49
7/31/202428,300 shares $429,028.00 +45.9%2.2%1.4 $15.16
7/15/202419,400 shares $473,166.00 -1.0%1.5%1.6 $24.39
6/30/202419,600 shares $346,136.00 -10.5%1.5%2.6 $17.66
6/15/202421,900 shares $460,338.00 +17.7%1.7%3.4 $21.02
5/31/202418,600 shares $433,938.00 -21.9%1.4%1.8 $23.33
5/15/202423,800 shares $615,944.00 -10.5%1.8%0.4 $25.88
4/30/202426,600 shares $742,140.00 -7.6%3.2%0.4 $27.90
4/15/202428,800 shares $720,000.00 -10.6%3.4%0.4 $25.00
3/31/202432,200 shares $757,666.00 -43.7%6.1%0.4 $23.53
3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00
2/29/202438,000 shares $666,900.00 -12.0%8.4%0.5 $17.55
2/15/202443,200 shares $415,152.00 -39.1%6.5%1.4 $9.61
1/31/202470,900 shares $596,269.00 +78.6%10.7%2.2 $8.41
1/15/202439,700 shares $363,255.00 -20.8%6.0%1.5 $9.15
12/31/202350,100 shares $576,150.00 +27.8%N/A2.3 $11.50
12/15/202339,200 shares $343,000.00 +10.4%5.9%2 $8.75
11/30/202335,500 shares $507,295.00 +25.0%5.3%2.1 $14.29
11/15/202328,400 shares $398,736.00 -97.6%4.3%7.7 $14.04
10/31/20231,180,000 shares $484,980.00 -6.4%4.4%7.1 $0.41
10/15/20231,260,000 shares $587,286.00 +4.1%4.7%7.1 $0.47
9/30/20231,210,000 shares $578,380.00 -4.0%4.5%6.7 $0.48
9/15/20231,260,000 shares $560,826.00 +4.1%4.6%7.6 $0.45
8/31/20231,210,000 shares $617,100.00 -13.6%4.4%5.8 $0.51
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
8/15/20231,400,000 shares $998,760.00 +15.7%5.1%6.2 $0.71
7/31/20231,210,000 shares $817,960.00 -4.7%4.4%8.5 $0.68
7/15/20231,270,000 shares $915,670.00 -1.6%4.6%9.8 $0.72
6/30/20231,290,000 shares $954,342.00 +7.5%4.7%10.2 $0.74
6/15/20231,200,000 shares $911,880.00 -3.2%4.4%9.6 $0.76
5/31/20231,240,000 shares $979,600.00 +6.9%4.5%15.1 $0.79
5/15/20231,160,000 shares $996,208.00 -1.7%4.2%12.6 $0.86
4/30/20231,180,000 shares $908,600.00 -0.8%4.3%13.4 $0.77
4/15/20231,190,000 shares $880,838.00 -0.8%4.4%13.6 $0.74
3/31/20231,200,000 shares $969,360.00 -1.6%4.4%12.2 $0.81
3/15/20231,220,000 shares $964,044.00 +8.9%4.5%11.5 $0.79
2/28/20231,120,000 shares $907,200.00 No Change4.1%10.3 $0.81
2/15/20231,120,000 shares $985,600.00 -4.3%4.1%17.3 $0.88
1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95
1/15/20231,130,000 shares $921,967.00 -4.2%4.1%16.4 $0.82
12/30/20221,180,000 shares $782,104.00 +8.3%4.3%17.9 $0.66
12/15/20221,090,000 shares $775,971.00 +2.8%4.0%18.1 $0.71
11/30/20221,060,000 shares $873,864.00 -1.9%3.9%15.5 $0.82
11/15/20221,080,000 shares $950,508.00 -3.6%4.0%15.2 $0.88
10/31/20221,120,000 shares $967,680.00 No Change4.1%10.2 $0.86
10/15/20221,120,000 shares $958,048.00 -8.2%4.1%6.3 $0.86
9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97
9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15
8/31/20221,270,000 shares $1.35 million -5.9%8.1%4.4 $1.06
8/15/20221,350,000 shares $1.85 million -19.2%6.1%1.5 $1.37
7/31/20221,670,000 shares $1.50 million +21.9%9.2%1.8 $0.90
7/15/20221,370,000 shares $934,340.00 -9.3%7.5%1.6 $0.68
6/30/20221,510,000 shares $1.13 million -15.2%8.3%1.8 $0.75
6/15/20221,780,000 shares $1.34 million +17.1%9.8%2.1 $0.76
5/31/20221,520,000 shares $837,520.00 -13.1%5.3%1.8 $0.55
5/15/20221,750,000 shares $743,750.00 No Change6.1%6.7 $0.43
4/30/20221,750,000 shares $1.21 million -0.6%6.1%7.5 $0.69
4/15/20221,760,000 shares $1.39 million +1.2%6.1%7.3 $0.79
3/31/20221,740,000 shares $1.26 million +3.6%6.1%6.9 $0.72
3/15/20221,680,000 shares $924,840.00 -13.0%5.9%5.7 $0.55
2/28/20221,930,000 shares $1.58 million +19.1%6.7%6.2 $0.82
2/15/20221,620,000 shares $1.20 million -0.6%5.7%5.1 $0.74
1/31/20221,630,000 shares $1.17 million +1.2%5.4%4.4 $0.72
1/15/20221,610,000 shares $1.42 million -5.3%5.3%3.5 $0.88
12/31/20211,700,000 shares $1.69 million -6.1%N/A2.8 $1.00
12/15/20211,810,000 shares $2.03 million -13.4%6.0%1.1 $1.12
11/30/20212,090,000 shares $2.59 million -2.3%8.0%1.1 $1.24
11/15/20212,140,000 shares $3.32 million +9.2%8.2%1.2 $1.55
10/29/20211,960,000 shares $2.80 million -22.8%8.4%1.1 $1.43
10/15/20212,540,000 shares $3.73 million +15.5%10.8%1.5 $1.47
9/30/20212,200,000 shares $3.37 million +39.2%9.4%1.4 $1.53
9/15/20211,580,000 shares $2.73 million -8.7%6.7%1.1 $1.73
8/31/20211,730,000 shares $3.24 million -14.4%7.4%1.6 $1.87
8/13/20212,020,000 shares $3.72 million -4.3%8.6%1.6 $1.84
7/30/20212,110,000 shares $4.05 million +2.9%9.0%1.4 $1.92
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
7/15/20212,050,000 shares $4.12 million -10.1%8.7%1.3 $2.01
6/30/20212,280,000 shares $5.20 million -5.4%10.3%0.4 $2.28
6/15/20212,410,000 shares $6.17 million +5.7%10.9%0.4 $2.56
5/28/20212,280,000 shares $5.61 million -11.3%10.7%0.4 $2.46
5/14/20212,570,000 shares $5.83 million -17.4%12.2%0.5 $2.27
4/30/20213,110,000 shares $8.21 million -39.9%14.8%0.5 $2.64
4/15/20215,170,000 shares $17.22 million +138.3%24.8%0.7 $3.33
3/31/20212,170,000 shares $5.82 million -4.4%10.4%0.7 $2.68
3/15/20212,270,000 shares $6.13 million -9.9%11.0%0.7 $2.70
2/26/20212,520,000 shares $6.40 million -17.7%15.9%0.5 $2.54
2/12/20213,060,000 shares $8.26 million -7.0%21.8%0.6 $2.70
1/29/20213,290,000 shares $6.58 million +12.3%25.4%0.7 $2.00
1/15/20212,930,000 shares $6.30 million +5.0%22.6%0.9 $2.15
12/31/20202,790,000 shares $5.38 million -26.8%21.5%1 $1.93
12/15/20203,810,000 shares $11.32 million +73.2%29.4%1.4 $2.97
11/30/20202,200,000 shares $4.73 million +5.3%18.2%3.4 $2.15
10/30/20201,940,000 shares $3.38 million -2.0%15.3%3.9 $1.74
10/15/20201,980,000 shares $3.45 million -1.0%16.5%4.2 $1.74
9/30/20202,000,000 shares $3.54 million +0.5%16.7%4.1 $1.77
9/15/20201,990,000 shares $3.88 million +4.7%16.6%3.8 $1.95
8/31/20201,900,000 shares $3.95 million +8.6%15.8%3.4 $2.08
8/14/20201,750,000 shares $4.25 million -0.6%18.7%2.9 $2.43
7/31/20201,760,000 shares $4.14 million -7.4%18.8%2.6 $2.35
7/15/20201,900,000 shares $4.45 million -9.5%21.8%4.4 $2.34
6/30/20202,100,000 shares $4.68 million +16.7%24.1%5.1 $2.23
6/15/20201,800,000 shares $4.99 million +0.6%20.6%4.8 $2.77
5/29/20201,790,000 shares $5.16 million +0.6%20.5%6.4 $2.88
5/15/20201,780,000 shares $5.30 million +5.3%20.4%5.5 $2.98

VTVT Short Interest - Frequently Asked Questions

What is vTv Therapeutics' current short interest?

Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 22,900 shares of VTVT short. 1.55% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest.

What is a good short interest ratio for vTv Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTVT shares currently have a short interest ratio of 1.0. Learn More on vTv Therapeutics's short interest ratio.

What is a good short interest percentage for vTv Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.55% of vTv Therapeutics' floating shares are currently sold short.

Is vTv Therapeutics' short interest increasing or decreasing?

vTv Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 22,900 shares, an increase of 42.2% from the previous total of 16,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is vTv Therapeutics' float size?

vTv Therapeutics currently has issued a total of 3,190,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 1,480,000 shares.

How does vTv Therapeutics' short interest compare to its competitors?

1.55% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to vTv Therapeutics: Atai Life Sciences (8.91%), Atyr PHARMA INC (11.66%), Phathom Pharmaceuticals, Inc. (21.93%), Cryoport, Inc. (5.39%), Astria Therapeutics, Inc. (6.79%), Aquestive Therapeutics, Inc. (11.75%), Aura Biosciences, Inc. (4.36%), Aurora Cannabis Inc. (9.05%), Compass Therapeutics, Inc. (9.30%), 2seventy bio, Inc. (7.96%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short vTv Therapeutics stock?

Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading up $1.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against vTv Therapeutics?

A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further.

How often is vTv Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:VTVT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners